- Report
- October 2023
- 140 Pages
North America
From €4254EUR$4,400USD£3,654GBP
- Report
- August 2022
- 120 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- March 2018
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- February 2023
- 66 Pages
North America
From €1450EUR$1,500USD£1,246GBP
- Report
- July 2023
- 101 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Book
- November 2013
- 320 Pages
- Book
- September 2019
North America
- Book
- December 2018
North America
- Book
- June 2016
North America
- Book
- December 2015
- 4176 Pages
Hematuria is a medical condition in which blood is present in the urine. It is a common symptom of many urological and nephrological diseases, including kidney stones, urinary tract infections, and prostate cancer. It can also be caused by trauma, medications, or other medical conditions. Diagnosis of hematuria typically involves a physical examination, urinalysis, imaging tests, and other laboratory tests. Treatment depends on the underlying cause and may include antibiotics, surgery, or other medications.
The hematuria market is a subset of the larger urology and nephrology market. It is composed of products and services related to the diagnosis and treatment of hematuria. This includes diagnostic tests, imaging equipment, medications, and surgical instruments.
Some companies in the hematuria market include Siemens Healthineers, Abbott Laboratories, B. Braun Melsungen AG, Olympus Corporation, and Stryker Corporation. Show Less Read more